Join Dr. Grace Chua and Dr. Michael Boivin as they explore the rapidly evolving role of pharmacologic therapies in obesity management, diving into GLP‑1-based treatments, addressing common myths, and highlighting key cardiovascular and metabolic impacts. Offering practical guidance, real‑world considerations, and insights into emerging therapies, this episode underscores the importance of multidisciplinary collaboration and provides clear, actionable takeaways for patient care.

This podcast is part of the Obesity and CVD Knowledge Mobilization Strategy, an initiative designed to equip healthcare providers with practical tools and evidence to address obesity as a major driver of cardiovascular disease.